Acelrx Pharmaceutica (ACRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ACRX | PYPD | JAGX | ||
Company | Acelrx Pharmaceutica | Polypid Ltd | Jaguar Health Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.7811 | 3.21 | 1.1700 | ||
High | 0.8775 | 3.21 | 1.3300 | ||
Low | 0.7784 | 2.86 | 1.1500 | ||
Last | 0.8600 | 3.00 | 1.2800 | ||
Change | +0.0600 | -0.06 | +0.1300 | ||
% Change | +7.50% | -1.96% | +11.30% | ||
Volume | 243,500 | 15,900 | 1,246,200 | ||
20-Day Average Volume | 154,540 | 49,465 | 709,415 | ||
Previous Close | 0.8000 | 3.06 | 1.1500 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.7658 | 2.95 | 1.0171 | ||
20-Day Raw Stochastic | 91.56% | 42.57% | 89.72% | ||
20-Day Relative Strength | 61.32% | 47.88% | 61.26% | ||
Weighted Alpha | -53.04 | -54.15 | -33.57 | ||
Today's Opinion | 24% Buy | 72% Sell | 40% Sell | ||
Previous Opinion | 8% Sell | 72% Sell | 40% Sell | ||
Last Month's Opinion | 24% Sell | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +16.15% since 01/02/24 | +3.81% since 12/27/24 | +24.27% since 12/27/24 | ||
Low | 0.7300 on 01/03/24 | 2.62 on 12/30/24 | 0.9656 on 12/31/24 | ||
High | 0.8775 on 01/09/24 | 3.25 on 12/30/24 | 1.3300 on 01/06/25 | ||
1-Month | |||||
%Chg | +18.03% since 12/08/23 | -0.66% since 12/06/24 | +33.89% since 12/06/24 | ||
Low | 0.6701 on 12/12/23 | 2.37 on 12/16/24 | 0.8435 on 12/16/24 | ||
High | 0.8775 on 01/09/24 | 3.85 on 12/24/24 | 1.3300 on 01/06/25 | ||
3-Month | |||||
%Chg | +28.45% since 10/09/23 | -16.32% since 10/04/24 | unch since 10/04/24 | ||
Low | 0.4250 on 11/14/23 | 2.37 on 12/16/24 | 0.8435 on 12/16/24 | ||
High | 0.8775 on 01/09/24 | 3.85 on 12/24/24 | 1.3400 on 10/08/24 | ||
6-Month | |||||
%Chg | -33.85% since 07/07/23 | -25.00% since 07/05/24 | -64.35% since 07/05/24 | ||
Low | 0.4250 on 11/14/23 | 2.37 on 12/16/24 | 0.8435 on 12/16/24 | ||
High | 1.4200 on 07/10/23 | 4.42 on 07/29/24 | 4.4300 on 07/22/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 14,579 | 14,680 | 13,568 | ||
Shares Outstanding, K | 16,952 | 4,797 | 11,798 | ||
Annual Sales | 1,770,000 | 0 | 9,760,000 | ||
Annual Net Income | 47,760,000 | -23,870,000 | -41,300,000 | ||
Last Quarter Sales | 120,000 | 0 | 3,110,000 | ||
Last Quarter Net Income | -1,360,000 | -7,760,000 | -9,850,000 | ||
60-Month Beta | 0.52 | 1.32 | 0.84 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.08 on 11/08/23 | -1.22 on 11/13/24 | -1.05 on 11/13/24 | ||
Latest Earnings Date | 11/08/23 | 02/12/25 | 11/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |